Nile Therapeutics Report issue

For profit Phase 1 Phase 2
Founded: San Mateo CA United States (2005)
Status: Acquired by Capricor Inc. (2013)

Organization Overview

First Clinical Trial
2007
NCT00482937
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Nile Therapeutics Inc.